MuhammadGAlamMD

PubMed

• 40 citations
  Effect of deferiprone, an oral iron chelator, in diabetic and non-diabetic glomerular disease
  Mohan Rajapurkar, Umapati Hegde, Amalkumar Bhattacharya, Muhammad G Alam, Sudhir V. Shah> ;Toxicology Mechanisms and Methods. 2013 Jan 1
• The role of iron in diabetes and its complications.
  Swaminathan, S., Fonseca, V.A., Alam, M.G., Shah, S.V.> ;Diabetes Care. 2007 Jul
• Cinacalcet for secondary hyperparathyroidism in hemodialysis recipients.
  Owda, A.K., Alam, M.G., Kumar, J.> ;N Engl J Med. 2004 Jul 8
• Parenteral iron therapy: beyond anaphylaxis.
  Alam, M.G., Krause, M.W., Shah, S.V.> ;Kidney Int. 2004 Jul
• Environmental lead exposure and chronic renal disease.
  Owda, A.K., Alam, M.G., Shah, S.V.> ;N Engl J Med. 2003 May 1
• 62 citations
  Role of iron in atherosclerosis.
  Sudhir V. Shah, Muhammad G Alam> ;American Journal of Kidney Diseases. 2003 Mar 1
• 12 citations
  Systolic blood pressure is the main etiology for poorly controlled hypertension.
  Muhammad G Alam, Yousri M. Barri> ;American Journal of Hypertension. 2003 Feb 1
• 18 citations
  Ciprofloxacin-induced acute interstitial nephritis and autoimmune hemolytic anemia.
  Salim Lim, Muhammad G Alam> ;Renal Failure. 2003 Jan 1
• Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy.
  Marshall, M.R., Golper, T.A., Shaver, M.J., Alam, M.G., Chatoth, D.K.> ;Am J Kidney Dis. 2002 Mar
• 148 citations
  Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy.
  Mark R. Marshall, Thomas A. Golper, Mary Jo Shaver, Muhammad G. Alam, Dinesh Chatoth> ;Kidney International. 2001 Aug 1
• Join now to see all